AstraZeneca

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom. 

CEO
Pascal Soriot
CEOPascal Soriot
Employees
89,900
Employees89,900
Headquarters
Cambridge, Cambridgeshire
HeadquartersCambridge, Cambridgeshire
Founded
1992
Founded1992
Employees
89,900
Employees89,900

AZN Key Statistics

Market cap
237.05B
Market cap237.05B
Price-Earnings ratio
37.10
Price-Earnings ratio37.10
Dividend yield
1.87%
Dividend yield1.87%
Average volume
7.95M
Average volume7.95M
High today
$76.90
High today$76.90
Low today
$75.43
Low today$75.43
Open price
$76.47
Open price$76.47
Volume
9.03M
Volume9.03M
52 Week high
$76.90
52 Week high$76.90
52 Week low
$60.47
52 Week low$60.47

AZN News

Yahoo Finance 18h
Top Analyst Reports for AstraZeneca, QUALCOMM & FedEx - Yahoo Finance

Thursday, May 3, 2024 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on...

Top Analyst Reports for AstraZeneca, QUALCOMM & FedEx - Yahoo Finance
TipRanks 2d
AstraZeneca's Calquence Shows Promise in Lymphoma Trial - TipRanks.com - TipRanks

AstraZeneca (AZN) has released an update. AstraZeneca’s Calquence, combined with chemoimmunotherapy, has shown a statistically significant improvement in progr...

TipRanks 2d
AstraZeneca announces results from interim analysis of ECHO Phase III trial

Positive high-level results from an interim analysis of the ECHO Phase III trial showed AstraZeneca’s Calquence in combination with standard-of-care chemoimmuno...

Analyst ratings

74%

of 31 ratings
Buy
74.2%
Hold
22.6%
Sell
3.2%

More AZN News

TipRanks 3d
AstraZeneca put volume heavy and directionally bearish

Bearish flow noted in AstraZeneca with 6,310 puts trading, or 1.5x expected. Most active are 5/24 weekly 64 puts and Oct-24 77.5 puts, with total volume in thos...

TipRanks 3d
AstraZeneca Shares Voting Rights Update - TipRanks.com - TipRanks

AstraZeneca (AZN) has released an update. AstraZeneca PLC, a leading biopharmaceutical company, announced that as of April 30, 2024, its issued share capital w...

Yahoo Finance 4d
AstraZeneca PLC Q1 2024 Earnings Call Transcript - Yahoo Finance

AstraZeneca PLC (NASDAQ:AZN) Q1 2024 Earnings Call Transcript April 25, 2024 AstraZeneca PLC misses on earnings expectations. Reported EPS is $1.03 EPS, expect...

AstraZeneca PLC Q1 2024 Earnings Call Transcript - Yahoo Finance
Benzinga 5d
AstraZeneca Admits Its COVID-19 Vaccine May Cause Blood Clotting Side Effect In Very Rare Case, But Causal Mechanism Unknown

AstraZeneca Admits Its COVID-19 Vaccine May Cause Blood Clotting Side Effect In Very Rare Case, But Causal Mechanism Unknown European pharma giant AstraZeneca...

AstraZeneca Admits Its COVID-19 Vaccine May Cause Blood Clotting Side Effect In Very Rare Case, But Causal Mechanism Unknown
TipRanks 5d
AstraZeneca's Truqap Set for EU Approval - TipRanks.com - TipRanks

AstraZeneca (AZN) has released an update. AstraZeneca PLC’s drug Truqap, in combination with Faslodex, has been recommended for EU approval for treating advanc...

TipRanks 5d
UK Stocks: AstraZeneca Shares Rise on Promising Breast Cancer Drug Updates - TipRanks.com - TipRanks

In top news on UK stocks, AstraZeneca PLC (GB:AZN) shares are rising today after the company released promising updates on two of its breast cancer drugs, Truqa...

Benzinga 5d
Double Good News For AstraZeneca's Breast Cancer Drugs

Loading... Loading... AstraZeneca plc AZN reported topline data from a metastatic breast cancer treatment study. The results showed that Enhertu (trastuzumab...

Double Good News For AstraZeneca's Breast Cancer Drugs
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.